Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC for Early-onset Androgenetic Alopecia
NCT04209803Phase 4Completed
- Sponsor
- Kafrelsheikh University
- Start
- Dec 2018
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of acetylcysteine in androgenetic alopecia (AGA), sponsored by Kafrelsheikh University. Started Dec 2018; status: completed.
02
Drugs
acetylcysteine
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT04209803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04209803.